| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 01/30/2001 | US6180136 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 01/30/2001 | CA2053268C Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |
| 01/25/2001 | WO2001005937A2 Conversion of a watson-crick dna to a hoogsteen-paired duplex |
| 01/25/2001 | WO2001005834A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | WO2001005823A2 Tryptase inhibitor |
| 01/25/2001 | WO2001005742A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 01/25/2001 | WO2001005480A2 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 01/25/2001 | WO2001005436A1 Method for producing antibodies in egg yolk and use of resulting antibodies |
| 01/25/2001 | WO2000066587A3 Polyamines and their use in therapy |
| 01/25/2001 | WO2000060080A3 Molecules of the immune system |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| 01/25/2001 | DE19934585A1 Treatment of dermatological disorders, e.g. pruritus, herpes simplex infection, psoriasis or acne, using tosyl chloramide salt, e.g. in ointment or gel base |
| 01/25/2001 | CA2381327A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | CA2379891A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 01/25/2001 | CA2379627A1 Inhibitor proteins |
| 01/25/2001 | CA2379618A1 Viral protein binding compositions and methods |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2376518A1 Conversion of a watson-crick dna to a hoogsteen-paired duplex |
| 01/24/2001 | EP1069903A1 Novel nucleoside analogs and uses in treating disease |
| 01/24/2001 | CN1061050C Ureido derivatives of naththalenephosphonic acids and process for their preparation |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004281A2 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | WO2001004123A2 Peroxide-based antimalarial compounds |
| 01/18/2001 | WO2001003681A2 Use of flavones, coumarins and related compounds to treat infections |
| 01/18/2001 | CA2379133A1 Human proteins involved in detoxification |
| 01/18/2001 | CA2378407A1 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | CA2375647A1 Use of flavones, coumarins and related compounds to treat infections |
| 01/17/2001 | EP1068327A2 DNA IMMUNIZATION AGAINST $i(CHLAMYDIA) INFECTION |
| 01/17/2001 | EP1068304A1 Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily |
| 01/17/2001 | EP1068293A1 Vaccination modalities |
| 01/17/2001 | EP1067961A2 Leishmania cysteine proteinases |
| 01/17/2001 | EP1067938A1 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine |
| 01/17/2001 | CN1280494A Agents for combating neospora spec |
| 01/17/2001 | CN1279945A Gastric floating slow-releasing tinidazole capsule and its preparing method |
| 01/16/2001 | US6174898 Method of treating filariae |
| 01/16/2001 | CA2150234E Combination of atovaquone with proguanil for the treatment of protozoal infections |
| 01/16/2001 | CA1341166C Antigenic proteins and vaccines containing them for prevention of coccidiosis |
| 01/11/2001 | WO2001002569A2 Human immune response molecules |
| 01/11/2001 | WO2001002567A1 16405 receptor, a g-protein coupled receptor |
| 01/11/2001 | WO2001002414A1 Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
| 01/11/2001 | WO2001001975A2 Hypoestoxides, derivatives and agonists thereof for use as antiparasitic agents |
| 01/11/2001 | WO2000062800A3 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 01/11/2001 | WO2000059904A3 Compounds and methods to treat cardiac failure and other disorders |
| 01/11/2001 | DE19931883A1 DNA kodierend für Beta-Tubulin und deren Verwendung DNA coding for beta-tubulin, and the use thereof |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/10/2001 | EP1066854A2 Anthelmintic compositions containing combinations of avermectins or milbemycins with bis-aryl compounds |
| 01/10/2001 | EP1066833A2 Cryopreserved cells, system for supplying cells on commission, and preventive or remedial method of infections or cancers |
| 01/10/2001 | CN1279686A Inhibitors of nucleoside metabolism |
| 01/10/2001 | CN1060483C Intermediate of doramectin for antiparastic chemical and its preparing method |
| 01/10/2001 | CN1060386C Complex traditional Chinese medicine preparation for treating brain cysticarosis and preparing method thereof |
| 01/09/2001 | US6172192 Polypeptide or peptide associated microorganism infection; for diagnosis and prevention protozoan infection of mammals |
| 01/09/2001 | US6172116 Use of aminoadamantane compounds as immunoregulators |
| 01/09/2001 | US6172104 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof |
| 01/09/2001 | US6172050 Quaternary ammonium interior salt containing phosphate group |
| 01/09/2001 | US6172038 Antipathogenic peptides and compositions comprising them |
| 01/09/2001 | US6171820 Saturation mutagenesis in directed evolution |
| 01/04/2001 | WO2001000812A2 22012, a novel human carboxypeptidase |
| 01/04/2001 | WO2001000231A2 Use of cpg as an adjuvant for malaria vaccine |
| 01/04/2001 | WO2000057917A3 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 01/04/2001 | WO2000044761A3 Ketolide antibiotics |
| 01/04/2001 | CA2376926A1 Use of cpg as an adjuvant for malaria vaccine |
| 01/03/2001 | EP1064947A1 In ovo vaccination of 1 type marek's disease virus |
| 01/03/2001 | EP1064272A1 Cyclooctadepsipeptides and their use for combating endoparasites |
| 01/03/2001 | EP1063992A1 Sulfurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations |
| 01/03/2001 | EP0637244B1 A strain of streptomyces avermitilis glycosylates avermectin compounds |
| 01/03/2001 | CN1060089C Omphalia lapidescens schroet injection of Chinese traditional medicine and preparation method |
| 01/03/2001 | CN1060043C Animal medicinal composition |
| 01/02/2001 | US6169090 Heterocyclic compounds and their therapeutic use |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078941A2 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | WO2000078732A1 Halopyrimidines |
| 12/28/2000 | WO2000078332A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | WO2000078268A2 Potentiation of chloroquine |
| 12/28/2000 | WO2000078247A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 12/28/2000 | WO2000061551A3 Pyrimidine-2-one derivatives as integrin receptor ligands |
| 12/28/2000 | WO2000046344A3 Non-stochastic generation of genetic vaccines and enzymes |
| 12/28/2000 | WO2000043495A3 33 human secreted proteins |
| 12/28/2000 | CA2377357A1 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | CA2375508A1 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | CA2375493A1 Human transport proteins |
| 12/28/2000 | CA2375407A1 Rna metabolism proteins |
| 12/28/2000 | CA2371924A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 12/27/2000 | EP1062214A1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels |
| 12/27/2000 | EP1022278A4 Tetracyclical derivatives from pyrimidine |
| 12/26/2000 | US6166048 Pharmaceutical compositions for inhibition of cytokine production and secretion |
| 12/26/2000 | US6166046 A synergistic mix ratio |
| 12/26/2000 | US6165735 Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof |
| 12/26/2000 | US6165502 Protein-lipid vesicles and autogenous vaccine comprising the same |
| 12/26/2000 | US6165469 Recombinant Entamoeba histolytica lectin subunit peptides and reagents specific for members of the 170 kD subunit multigene family |
| 12/26/2000 | CA2183453C Antiparasitic agents |
| 12/21/2000 | WO2000077262A1 Synthetic ligation reassembly in directed evolution |
| 12/21/2000 | WO2000077255A1 49 human secreted proteins |
| 12/21/2000 | WO2000077173A1 42 human secreted proteins |
| 12/21/2000 | WO2000076985A1 Cyclo-imino depsipeptides and their utilization in controlling endoparasites |
| 12/21/2000 | WO2000076517A1 Il-8 receptor antagonists |
| 12/21/2000 | WO2000076516A1 Il-8 receptor antagonists |
| 12/21/2000 | WO2000076515A1 Il-8 receptor antagonists |